Jan Ellenberg is a Senior Scientist and Head of the Cell Biology and Biophysics Unit at the European Molecular Biology Laboratory (EMBL) since 2006 and 2010, respectively. He also serves as EMBL Delegate to the Euro-BioImaging Interim Board since 2014 and has coordinated multiple EMBL units and pan-European imaging infrastructure projects. PhD in biochemistry (1998, NIH & Freie Universität Berlin) Diploma in biology (1994, Universität Hamburg) His research focuses on cell biology , nuclear and chromosome dynamics , and advanced microscopy technologies . Key areas include mitosis/meiosis , nuclear pore complex organization , and super-resolution/light-sheet microscopy development. Scientific awards include the Allen Distinguished Investigator (2017), ERC Advanced Investigator (2016), and Walter Flemming Medal (2004). His publications (>130) frequently appear in top journals like Nature, Science, and Cell. 2017 Allen Distinguished Investigator 2016 ERC Advanced Investigator 2016 Honorary Doctor of Philosophy at Åbo Akademi University 2006 EMBO Member
Assoc. Prof. Dietmar Pum is a leading researcher at the Institute of Biophysics, University of Natural Resources and Life Sciences, Vienna (BOKU). With a career spanning over three decades, he has pioneered work on S-layer proteins as nanobiotechnological tools and biomimetic surface functionalization. His research bridges microbiology, biophysics, and nanomaterials science. Education & Career Doctorate (1984) and Habilitation (1992) at Vienna University of Technology Awarded FEBS (1987) and EMBO (1982) fellowships Assoc. Univ. Prof. since 1997, Deputy Head of Biophysics Institute since 2014 Research Focus Dr. Pum's work centers on leveraging S-layer proteins for nanoscale fluid mechanics , molecular imprinting , and biohybrid materials . His projects explore: Self-assembly of 2D protein crystals Functionalization of carbon nanotubes Biomimetic sensor development Applications in diagnostics and environmental technology Publication Trends His recent publications (2025-2019) highlight interdisciplinary advancements in: Nanoscale biofluid dynamics Gold nanoparticle synthesis via microbial enzymes Archaeal S-layer characterization Protein-directed nanomaterials Biosensor platforms Lipid quantification via machine learning Scientific Recognition Philip Morris Research Prize (1998) Cardinal Innitzer Prize (1992) ÖAGM Prize (1986) Peer reviewer for Nature Materials , Advanced Materials , and Biophysical Journal Advising & Collaborations Dr. Pum has supervised over 15 theses, mentoring students in topics ranging from Caenorhabditis elegans imaging to nanomembrane fabrication. He leads international collaborations under EU Horizon and FWF grants, including the Stimuli Responsive Materials project (2020-2025). Labs & Networks As a core member of BOKU's Center for NanoBiotechnology and the Ludwig Boltzmann Institute for Molecular Nanotechnology , he develops bioinspired nanomaterials and contributes to global programs in molecular self-assembly.
Professor Jana Zaumseil is a distinguished academic at Heidelberg University, holding the position of Professor for Applied Physical Chemistry at the Faculty of Chemistry and Earth Sciences since 2014. She also maintains a co-opted position with the Faculty of Physics and Astronomy since 2016. Currently serving as Executive Director of the Institute for Physical Chemistry and Spokesperson for the DFG Research Training Group GRK 2948, she leads the Zaumseil research group (also known as the Nanomaterials for Optoelectronics group) at Heidelberg University's Institute for Physical Chemistry. Her educational background includes a PhD in Physics from the University of Cambridge (2003-2007) with a Gates Cambridge Trust Scholarship, and a Diplom (equivalent to M.Sc.) in Chemistry from the University of Leipzig (1997-2022). Prior to her position at Heidelberg, she served as Professor for Nanoelectronics at Friedrich-Alexander-Universität Erlangen-Nürnberg (2009-2014), and completed postdoctoral work at Argonne National Laboratory (2007-2009) following an internship at Bell Laboratories (2002-2003). Zaumseil's research program focuses on the optical and electronic properties of carbon-based nanomaterials, particularly single-walled carbon nanotubes (SWCNTs) and organic semiconductors. Her group specializes in processing, functionalization, characterization and application of these unconventional semiconductors for optoelectronic devices and sensors. They investigate charge transport and light-matter interaction using a wide range of experimental techniques including synthesis, optical spectroscopy, atomic force microscopy, device fabrication, and electrical/optical device characterization. Their work bridges fundamental understanding with potential applications in sensing, imaging, circuits, and energy conversion. Analysis of her recent publications reveals a strong trend toward defect engineering in carbon nanotubes, particularly creating and optimizing luminescent sp 3 defects for near-infrared applications. Her research increasingly integrates fundamental studies of charge transport with practical device applications, especially in neuromorphic computing, biosensors, and thermoelectrics. The interdisciplinary nature of her work is evident in the combination of chemistry, physics, and materials science approaches across her publication record. Dan Maydan Prize for Nanoscience and Nanotechnology (2024) Jahrespreis der Universität Heidelberg (2023) ERC Consolidator Grant (2019) ERC Starting Grant (2012) Alfried-Krupp-Award for Young University Professors (2010) Professor Zaumseil has secured substantial research funding including multiple ERC grants and leads several major collaborative projects such as the ERC Advanced Grant SCALE-NT, Collaborative Research Center SFB 1249, Cluster of Excellence 3D Matter Made to Order, and Research Training Group GRK 2948. She has mentored numerous doctoral and master's students, with her group recently receiving recognition including a Student Poster Presentation Award for Niklas Herrmann. As Dean of the Faculty of Chemistry and Earth Science (2019-2021) and current Vice Dean (2021-), she has played significant leadership roles within the university structure. The Zaumseil research group operates within Heidelberg University's Institute for Physical Chemistry, utilizing advanced facilities for nanomaterial synthesis, optical spectroscopy, and device characterization. The group participates in several major collaborative initiatives including the Cluster of Excellence 3D Matter Made to Order and the Collaborative Research Center SFB 1249, reflecting its integration within Heidelberg's broader research ecosystem focused on molecular systems and materials science.
Jian Hu is a Professor at Michigan State University (MSU) in the Department of Biochemistry & Molecular Biology, with joint appointments in the Department of Chemistry and the BioMolecular Science Gateway. His research integrates structural biology, biochemistry, and biophysics to investigate macromolecular mechanisms in biology and biomedicine, focusing on bio-metal utilization and homeostasis. Ph.D., Peking University, 2004 B.S., Beijing Medical University, 1999 Associate Research Scientist, Yale University (2008–2013) Postdoctoral Research Associate, Florida State University (2005–2007) The Hu lab targets three major projects: (1) ZIP metal transporters, exploring alternating access mechanisms and substrate specificity; (2) Lar proteins, analyzing Ni-pincer cofactor biosynthesis and catalytic mechanisms; and (3) PIPK lipid kinases, studying membrane sensing and inhibitor development. Collaborations with Dr. Robert P. Hausinger and Dr. Xuefei Huang advance drug discovery and structural elucidation. Recent publications highlight interdisciplinary work, blending plant biology (phenylalanine metabolism, peroxisome dynamics) with computational methods (watermarking algorithms, signal processing). His collaborations extend to engineering and medicine, emphasizing functional characterization of proteins and drug target validation. Scientific Awards: Invited State-of-the-Art Review, FEBS Journal 2021 Current courses include BMB 829: Special Problems in Macromolecular Analysis & Synthesis and CEM 999: Doctoral Dissertation Research . The lab employs X-ray crystallography, cryo-EM, NMR, and biochemistry to resolve atomic-level structures and functions of critical macromolecules, including ZIP4 and PIP5Kγ.
Thomas Graham is an Assistant Professor and PhytoGro Research Chair in Controlled Environment Systems at the University of Guelph, where he also serves as R&D Manager for the Controlled Environment Systems Research Facility (CESRF). His academic journey includes a BSc in Environmental Sciences from the University of Guelph and Stirling University (1997), an MSc in Horticulture (2001), and a PhD in Environmental Biology (2012), all from the University of Guelph. He completed a NASA Post-Doctoral Fellowship (2012–2015) at Kennedy Space Center, focusing on bioregenerative life-support systems for space exploration. Dr. Graham’s research expertise spans controlled environment agriculture (CEA) , space biology , medicinal crop production , and water remediation . He leads projects addressing food security, crop diversification in urban farming, and sustainable practices for high-intensity agriculture. Key initiatives include developing CEA systems for medical crops, optimizing tree crops for spaceflight, and advancing composting-based closed-loop systems. His scientific contributions are reflected in roles as Associate Editor for Gravitational and Space Research and Editor for special issues on Agriculture in Space . He collaborates with NASA, USDA, OMAFRA, and international agencies like the German Space Agency (DLR). Awards include the NASA Post-Doctoral Research Fellowship. Dr. Graham emphasizes mentorship, conducting bi-weekly graduate meetings and fostering student autonomy while providing structured support. His lab integrates interdisciplinary approaches to tackle global challenges, from climate resilience to lunar food production.
Mattias Brunström serves as Assistant Professor of Cardiology and Associate Professor of Epidemiology at Umeå University's Faculty of Medicine within the Department of Public Health and Clinical Medicine, Section of Cardiology. He is concurrently a resident physician at Norrlands University Hospital and holds leadership roles as chairman of Sweden's national hypertension working group and scientific secretary of the Swedish Society for Hypertension, Stroke and Vascular Medicine, with active participation in the European and International Societies of Hypertension. His academic foundation includes a 2018 PhD thesis examining blood pressure-lowering treatment effects across different blood pressure levels through systematic reviews and meta-analyses of randomized clinical trials. This doctoral work established his expertise in evidence-based cardiovascular therapeutics and epidemiological methodology. Dr. Brunström's research program centers on cardiovascular disease risk factors, with specialized focus on hypertension pathophysiology and aortic diseases. His group investigates how adolescent blood pressure levels predict future cardiovascular events, examining interactions with obesity, physical fitness, and diabetes to improve risk stratification. They also analyze differential effects of antihypertensive drug classes on cardiovascular outcomes and study risk factors for aortic dissection/rupture to optimize preventive surgical interventions. This work addresses critical gaps in managing the world's leading cause of death, where uncontrolled hypertension contributes to 10 million annual fatalities despite effective treatments. Analysis of his 2024-2025 publications reveals dominant themes in hypertension guideline development, treatment threshold controversies, and cardiovascular risk assessment. His work frequently challenges conventional approaches (e.g., questioning excessive treatment of 'elevated' blood pressure in elderly patients) while advancing evidence for lifestyle interventions and beta-blocker utility. Methodologically, his research leverages large cohort studies (including 1.4 million enlistee data), systematic reviews, and international collaborations through societies like ESH and ISH to translate epidemiological findings into clinical practice. Dr. Brunström leads multiple funded research initiatives including 'Remission of type 2 diabetes through eHealth' (2022-2028) and 'VIPviza' (2013-2027), directing a multidisciplinary team that bridges clinical cardiology, epidemiology, and public health. His advisory role extends to national guideline committees and international hypertension societies where he shapes clinical practice through evidence synthesis and position papers. Based at Norrlands University Hospital's Cardiology Section, his research group operates within Umeå University's strong cardiovascular research ecosystem, maintaining active collaborations with the Swedish National Diabetes Register and international consortia. Their work emphasizes real-world applicability, examining topics like bedtime dosing of antihypertensives and self-report diagnostic tools to overcome barriers in hypertension control where only 25% of affected individuals achieve target blood pressure levels.
Nicolas Chiaruttini is a Lecturer and Scientist at École Polytechnique Fédérale de Lausanne (EPFL), affiliated with the School of Life Sciences. He serves in the BioImaging and Optics Core Facility (PTBIOP) and contributes to doctoral education through the EDMS - Teaching program. Institution: École Polytechnique Fédérale de Lausanne (EPFL) School: School of Life Sciences Department: BioImaging and Optics Core Facility Roles: Scientist, Lecturer Office: AI 0140, Building AI, Station 15, 1015 Lausanne, Switzerland Contact: +41 21 693 96 29 | nicolas.chiaruttini@epfl.ch ORCID: 0000-0003-4722-6245 Unit Websites: BioImaging and Optics Core Facility , EDMS Program His research and professional interests center on bioimaging, optics, and image processing, particularly in the context of life sciences and micro/nano-sciences. These areas are reflected in his dual role supporting advanced imaging technologies and teaching in doctoral programs. He teaches the course Image Processing for Life Science , which integrates computational techniques with biological imaging applications. While no recent publications or awards are listed in the provided text, his work is aligned with interdisciplinary research at the intersection of engineering, physics, and biology. Nicolas Chiaruttini is actively contributing to both research infrastructure and academic education at EPFL, demonstrating a commitment to advancing scientific methodology and training the next generation of researchers in quantitative imaging and analysis.
Peter Burke is a Professor of Electrical Engineering and Computer Science (joint appointments in Biomedical Engineering and Materials Science and Engineering ) at the Samueli School of Engineering, University of California, Irvine . His research bridges nanoelectronics with biotechnology , focusing on carbon nanotubes , graphene devices , and mitochondrial bioenergetics . He has received prestigious Young Investigator Awards from the Office of Naval Research and Army Research Office. Education: B.A. in Physics, University of Chicago (1992) Ph.D. in Physics, Yale University (1998) His work spans quantum electronics , high-speed semiconductor devices , and bio-nano interfaces . Recent publications highlight drone technology , mitochondrial electrical activity , and AI-driven nanoscale sensing . Research trends include terahertz spectroscopy , super-resolution imaging , and open-source medical devices like the NanoStat potentiostat . Scientific Awards Young Investigator Award, Office of Naval Research Young Investigator Program Award, Army Research Office As director of the BurkeLab , he develops nano-electronic interfaces for biological systems, including mitochondrial membrane potential assays and graphene-based biosensors . His lab's innovations in carbon nanotube arrays and scanning microwave microscopy have advanced bio-nano applications.
Tarek Fahmy serves as Associate Professor of Biomedical Engineering at Yale University's School of Engineering with additional appointments in Immunobiology. His research focuses on biomaterials-driven immunotherapy and immunodiagnostics, directing the Fahmy Laboratory in Yale's Malone Engineering Center. The lab develops nano- and micro-scale systems for artificial antigen presentation, vaccine delivery, and non-invasive immune monitoring, with applications in cancer immunotherapy and autoimmune disease treatment. Ph.D., The Johns Hopkins University Dr. Fahmy pioneers biomimetic material design to modulate immune responses through four core approaches: artificial antigen-presenting cell platforms using biodegradable polymers for T cell stimulation; modular nanoparticle vaccines enabling rapid pathogen response; label-free electronic sensors for real-time immune monitoring; and MRI-based cellular tracking of immune cells. His work integrates polymer chemistry, nanotechnology, and immunology to create adaptable systems for targeted drug delivery—particularly in lupus treatment—and cancer immunotherapy, emphasizing FDA-approved biocompatible materials for clinical translation. Analysis of his publication record reveals consistent innovation in nanomaterial applications for immune modulation. Key trends include development of pH-responsive dendrimers for dual drug delivery/imaging, carbon nanotube-based platforms for enhanced lymphocyte activation, and nanowire sensors enabling label-free T cell response detection. His research demonstrates increasing focus on translational applications , with recent work targeting autoimmune T cells in lupus and developing modular vaccine systems against emerging pathogens. Early Career Award from the Coulter Foundation (2006) for "Multimodal Nanoparticles for Targeting Autoimmune T Cells in Systemic Lupus Erythematosus" Ranked among top five translational junior faculty by Bioentrepreneur (Nature Biotechnology) in 2013 Dr. Fahmy leads a multidisciplinary team supported by National Institutes of Health (NIH), National Science Foundation (NSF), Yale Institute of Nanoscale and Quantum Engineering, and Wallace Coulter Foundation grants. His lab maintains active collaborations with Yale School of Medicine clinicians including Dr. Joseph Craft (Rheumatology Chief) and imaging specialists, focusing on translating nanoparticle technologies from bench to bedside. Current projects emphasize clinical applications for autoimmune disease diagnosis and targeted therapy. The Fahmy Laboratory occupies 1,700 sq. ft. in Yale's Malone Engineering Center, featuring polymer formulation facilities, biosafety level 2+ tissue culture suites, cell analysis equipment, and animal study infrastructure. The lab shares Yale School of Medicine resources including 4T/8T/11T MRI scanners and Yale Bioimage Suite® for advanced imaging analysis, enabling integrated research from materials synthesis to in vivo validation.
Dr. Samet Sahin is a Lecturer in Chemical Engineering at Lancaster University's School of Engineering. He holds a PhD and professional designations including FHAE (Fellow of Advance HE), AMIChemE (Associate Member of the Institution of Chemical Engineers), and MRSC (Member of the Royal Society of Chemistry). His academic journey includes positions at Bilecik Şeyh Edebali University and postdoctoral work with distinguished advisors including Prof. John A. Rogers. Dr. Sahin's research focuses on developing healthcare solutions through biochemical systems and material science, particularly in bioelectrode development, device design, and alternative materials. His work aims to translate basic research into practical healthcare products and devices, especially wearable and implantable biosensors. His publications show a strong emphasis on electrochemical biosensors for glucose detection, biofuel cells, and aptamer-based detection systems for various analytes including mycotoxins, bisphenol-A, and medical biomarkers. His research group has received funding from multiple international sources including TÜBİTAK (Scientific and Technological Research Council of Türkiye), TÜSEB (Health Institutes of Türkiye), and non-profits like Breakthrough T1D (USA) and the Fulbright Commission. The group maintains an interconnected structure that allows researchers from different backgrounds to collaborate on various topics. Dr. Sahin has received several professional awards including Research Excellence Awards from Bilecik SE University (2022, 2023) and a Fulbright Post Doctoral Fellowship (2020). His work has been recognized with the Engineering YES Elevator Pitch Prize (2013). As an educator, he serves as Module Convenor for ENGR265 Chemical Engineering Laboratory Projects and teaches multiple engineering modules including Fundamentals of Engineering Science and Chemical Process Design Project. He has supervised PhD student Jack Morley and numerous undergraduate students. Notably, Dr. Sahin has an impressive background in Taekwondo, having been a member of the Turkish National Team, winning a silver medal at the European Taekwondo Championship, and co-founding the NeoDo Taekwondo Academy in 2025.
Christoph J. Fahrni is a Professor at the School of Chemistry and Biochemistry, Georgia Institute of Technology. He earned his M.S. from the Federal Institute of Technology (ETH) in Zurich and a Ph.D. in Chemistry from the University of Basel in 1995. After postdoctoral work at Northwestern University, he joined Georgia Tech in 1999, where his research focuses on metal ion biochemistry, particularly copper and zinc, using fluorescent probes and X-ray fluorescence imaging. Education: M.S., Federal Institute of Technology (ETH), Zurich Ph.D., University of Basel, 1995 His research integrates synthetic fluorescent probes and X-ray fluorescence microscopy to study intracellular metal ion dynamics, including copper trafficking, zinc homeostasis, and their roles in diseases like Menkes syndrome. The lab develops high-affinity ligands for copper buffering, investigates P-type ATPase transporters, and uses 3D X-ray tomography to map metals in zebrafish embryos. Key methodologies include ratiometric two-photon microscopy and bioorganometallic catalyst design. Recent publications highlight advancements in subzeptomolar copper probes, dynamic zinc imaging during development, and metal chelation therapy applications. Collaborative projects with Prof. Robert Dickson explore low-background fluorescent protein imaging. The Fahrni group trains graduate students like Daisy Bourassa and Adam McCallum, focusing on biochemical copper/zinc interactions and probe development.
Maeva Dhaynaut is an Instructor in the Department of Radiology & Biomedical Imaging at Yale School of Medicine. Her academic appointment is within the Division of Bioimaging Sciences, focusing on positron emission tomography (PET) research and applications. Dr. Dhaynaut's research spans multiple areas of molecular and neuroimaging, with particular emphasis on: Development and application of PET radiotracers for neurological disorders Tau imaging in Alzheimer's disease and related neurodegenerative conditions Opioid receptor imaging and neuropsychiatric applications Quantitative imaging methods and kinetic modeling Novel radiopharmaceutical development for CNS targets Her recent publications demonstrate strong expertise in tau PET imaging with tracers like [18F]MK6240, with applications ranging from Alzheimer's disease to sports-related neurodegeneration in former football players. She has also made significant contributions to opioid receptor imaging and potassium channel imaging. Dr. Dhaynaut frequently employs advanced computational methods including diffusion models and Bayesian approaches for kinetic parameter estimation in dynamic PET imaging. Dr. Dhaynaut's collaborative research network includes prominent scientists such as Georges El Fakhri, Marc David Normandin, and Nicolas Guehl. Her work spans from basic radiopharmaceutical chemistry through preclinical validation to clinical applications, demonstrating a comprehensive translational research approach.
Professor Pascal Fua is a distinguished faculty member at EPFL (Swiss Federal Institute of Technology) in the School of Computer and Communication Science. He joined EPFL in 1996 and currently serves as Head of the Computer Vision Laboratory (CVLAB). His extensive research spans multiple cutting-edge areas in computer vision and geometric deep learning, with applications ranging from 3D reconstruction to medical imaging and aerodynamic optimization. Dr. Fua's research interests encompass Computer Vision, 3D Reconstruction, Shape Modeling, Geometric Deep Learning, Medical Image Analysis, Augmented Reality, Motion Recovery, Surface Mesh Processing, and Aerodynamic Shape Optimization. His work demonstrates a remarkable ability to bridge theoretical computer vision with practical applications across diverse domains. His research has evolved from traditional geometric computer vision techniques to incorporating deep learning approaches for 3D modeling, with recent focus on differentiable rendering, implicit surface representations, and applications in medical imaging and engineering design. His publication record shows a consistent trajectory of high-impact research, with recent work focusing on differentiable iso-surface extraction, geometric deep learning for aerodynamic shape optimization, and novel approaches to 3D reconstruction. His work spans both theoretical advances in computer vision algorithms and practical applications in medical imaging, autonomous driving, and computational fluid dynamics. IEEE Fellow Multiple ERC Grants recipient Associate Editor of IEEE Transactions for Pattern Analysis and Machine Intelligence Throughout his career, Professor Fua has mentored numerous PhD students who have gone on to make significant contributions in computer vision and related fields. His laboratory has established collaborations across multiple disciplines, including medical imaging, aerospace engineering, and neuroscience, demonstrating the broad applicability of his research. His current work continues to push the boundaries of geometric deep learning and 3D vision, with particular emphasis on making these techniques more practical and applicable to real-world engineering and medical problems.
Nediljko Budisa is a Professor and Tier 1 Canada Research Chair in Chemical Synthetic Biology and Xenobiology at the University of Manitoba's Faculty of Science, Department of Chemistry. His research program focuses on expanding the fundamental biochemical capabilities of living systems through genetic code engineering and synthetic biology approaches. Dr. Budisa's research spans multiple cutting-edge areas in synthetic biology, with particular emphasis on genetic code expansion , non-canonical amino acid incorporation , and protein engineering . His laboratory employs both classical biochemical techniques and advanced computational methods to develop orthogonal translation systems, engineer novel enzymes, and create synthetic cells with expanded biochemical repertoires. His work bridges chemistry, biology, and engineering to address fundamental questions about life processes while developing practical applications in biotechnology and medicine. Analysis of Dr. Budisa's publication record reveals a consistent trajectory of innovation in genetic code engineering, with recent work increasingly integrating machine learning approaches for protein design. His research spans from fundamental studies of protein structure-function relationships to applied research in metabolic engineering and antiviral strategies, demonstrating the versatility of synthetic biology approaches. Tier 1 Canada Research Chair in Chemical Synthetic Biology and Xenobiology Dr. Budisa leads an active research program supported by his Canada Research Chair position, with extensive collaborations across Canada and internationally. His work has resulted in numerous patents and commercial applications in biotechnology. He actively participates in the synthetic biology community through initiatives like Prairie iGEM BioExM and has delivered public lectures on methodological challenges in expanded genetic code research. His research is conducted through the Chemical Synthetic Biology and Xenobiology laboratory at the University of Manitoba, where his team explores the social, cultural, educational, ethical and philosophical aspects of synthetic biology alongside technical innovations, reflecting a comprehensive approach to advancing this transformative field.
Edward Jenkins is a Postdoctoral Researcher at the University of Oxford, affiliated with Balliol College. He is a member of the Davis Group, focusing on T-cell Biology and its intersections with proteomics, immunology, and cell signaling. His research spans diverse areas such as: T-cell activation mechanisms and membrane dynamics Vaccine adjuvant responses in lymph nodes CAR-T cell engineering for therapeutic specificity Proximity proteomics in inflammatory pathways Computational methods for 3D cell segmentation Recent publications highlight his work in immune receptor signaling, deubiquitinase substrate discovery, and nanoscale imaging of T-cell interactions. His studies often bridge molecular and cellular immunology with advanced imaging and computational tools, aiming to enhance cancer immunotherapy and vaccine design. Edward contributes to collaborative research within the Davis Group, utilizing techniques such as localisation microscopy and free-standing membrane platforms to investigate immune cell dynamics.
